Akèy › Pye Dyabetik
Etid klinik pou Pye Dyabetik ap rekrite nan Etazini
53 etid pou Pye Dyabetik ap rekrite patisipan nan sit atravè Etazini.
Vil ki gen plis etid
- Miami, FL8 etid
- Houston, TX7 etid
- Pittsburgh, PA7 etid
- Los Angeles, CA7 etid
- Roanoke, VA5 etid
- St. Louis, MO5 etid
- Kendall, FL4 etid
- Atlanta, GA4 etid
- Vista, CA4 etid
- Coral Springs, FL4 etid
- Columbus, OH4 etid
- Fresno, CA3 etid
- Tucson, AZ3 etid
- McAllen, TX3 etid
- Phoenix, AZ3 etid
- Doral, FL3 etid
- Pompano Beach, FL3 etid
- Tulsa, OK3 etid
Pa eta
- Arizona6 etid
- Florid15 etid
- Georgia6 etid
- Illinois3 etid
- Kalifòni15 etid
- Lwizyàn4 etid
- Michigan4 etid
- Missouri3 etid
- New York6 etid
- North Carolina5 etid
- Ohio7 etid
- Oklahoma4 etid
- Pennsylvania9 etid
- Texas15 etid
- Virginia5 etid
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
Evaluating Several Cellular, Acellular, and Matrix-like Products (CAMPs) and Standard of Care Versus Standard of Care Alone in the Management of Nonhealing Diabetic Foot and Venous Leg Ulcers.
Ap rekriteFaz 4
Laj 21 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT06826339Transverse Tibial Bone Transport (TTT) in the Management of Chronic Diabetic Lower Extremity Wounds
Ap rekrite
Laj 22 ak plis · Tout sèks · Mizajou Sep 14, 2026 · NCT07444593DFC 004 Biomarkers for Active Diabetic Foot Ulcers
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Sep 9, 2026 · NCT06104969Diabetic Foot Ulcer Imaging- Study 2
Ap rekrite
Laj 21 a 100 · Tout sèks · Mizajou Sep 4, 2026 · NCT03942081Phase 2a Dose Finding Study of Nu-3 Gel in Subjects With Mild iDFU
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 2, 2026 · NCT07565506Evaluating the Efficacy of Perinatal Membrane Allografts in Addition to the Standard of Care for the Treatment of Non-healing Diabetic Foot Ulcers.
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Sep 2, 2026 · NCT06437028Phase 1 Study of VELGRAFT, a Living Cellular Construct, in the Management of Chronic Diabetic Foot Ulcers Which Have Attained Granulation Tissue
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 2, 2026 · NCT07498218CARE-D-FOOT-Nav Pilot
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Sep 2, 2026 · NCT07143175Miro3D Wound Matrix for Treatment of Diabetic Foot Ulcers
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Aug 13, 2026 · NCT07632001Evaluating the Efficacy of OCM™ (Omeza® Complete Matrix) in the Treatment of Diabetic Foot Ulcers
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Aug 4, 2026 · NCT07161830WIREDUP: Wearable Insoles for Recurrent Diabetic Ulcer Prevention
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Jul 14, 2026 · NCT05950659CAMPR-II RWE TRIAL: A Saline-hydrated Allogeneic Dual-layer Amniotic Membrane Product or a Synthetic, Resorbable Polymeric Wound Matrix to a Coarsened Exact Matched Retrospective Control Cohort of Hard to Heal DFUs and VLUs
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Jul 14, 2026 · NCT07701590Evaluating the Efficacy NeoThelium FT in the Treatment of Diabetic Foot Ulcers
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Jun 17, 2026 · NCT06938685Exercise Enhances Wound Healing in Patients With Diabetic Foot Ulcers
Ap rekrite
Laj 20 a 80 · Tout sèks · Mizajou Jun 11, 2026 · NCT04791449Mirragen Diabetic Foot Ulcer Study
Ap rekriteEtid obsèvasyon
Laj 18 a 80 · Tout sèks · Mizajou Jun 4, 2026 · NCT06598241Randomized Evaluation of Nonhealing Diabetic Foot Ulcers With Exclusive Wound Therapy
Ap rekriteFaz 4
Laj 18 ak plis · Tout sèks · Mizajou May 19, 2026 · NCT07086443Efficacy of a Topical Palmitated Formulation of Capsaicin (Capsadyn®) In the Treatment of Diabetic Neuropathic Foot Pain
Ap rekriteFaz 1 bonè
Laj 25 a 75 · Tout sèks · Mizajou Apr 20, 2026 · NCT07260656Study Assessing Complete Wound Healing by Comparing Surgenex® PelloGraft in Treating DFU and SanoGraft® in Treating VLU to SOC
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Apr 7, 2026 · NCT06515093A Prospective Clinical Study to Evaluate the Effectiveness and Safety of Xcell Amnio MatrixTM (XAM) in the Management of Chronic Non-healing DFUs
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Mar 31, 2026 · NCT07116174Diabetic Foot Ulcer (DFU) Biofilm Infection and Recurrence
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Mar 18, 2026 · NCT05172089Prospective Case Series Evaluating the Efficacy and Safety of NeoThelium FT for Diabetic Foot Ulcers
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Mar 12, 2026 · NCT07039396Modified Platform Trial Assessing Multiple CAMPs and SOC vs SOC Alone in the Treatment of Hard-to-Heal DFUs
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Mar 2, 2026 · NCT06449638Trial to Evaluate the Safety and Effectiveness of Treatment With COMS One Device in Subjects With Diabetic Foot Ulcers
Ap rekrite
Laj 22 a 90 · Tout sèks · Mizajou Feb 17, 2026 · NCT05758545Evaluation of ELU42 Topical Spray for the Treatment of Diabetic Foot Ulcers
Ap rekriteFaz 1/2
Laj 18 a 75 · Tout sèks · Mizajou Feb 12, 2026 · NCT07396376A Multicenter, Prospective, Controlled Clinical Trial Evaluating the Efficacy of a Single Layer Placental-based Allograft and Standard of Care in the Management of Nonhealing Diabetic Foot Ulcers
Ap rekriteFaz 4
Laj 18 ak plis · Tout sèks · Mizajou Feb 11, 2026 · NCT07159282Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.